Search all content on GOV.UK

Did you mean Abilify?

• Aripiprazole (Abilify and generic brands): risk of pathological gambling

  Healthcare professionals prescribing aripiprazole are reminded to be alert to the risk of addictive gambling and other impulse control disorders. Healthcare professionals should advise patients, their families and friends to be alert to these risks.

  • Updated: 18 December 2023
• Aripiprazole (Abilify): reminder on known risk of gambling disorder

  The MHRA has reminded healthcare professionals prescribing aripiprazole to be alert to the known risk of patients developing addictive gambling, following a rise in the number of reports received in 2023

  • Updated: 18 December 2023
• Antipsychotic medicines
  • Updated: 25 August 2005
• Clinical platform trials for coronavirus (COVID-19) treatments

  Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.

  • Updated: 31 March 2023
• Access, new active substance and biosimilar work sharing initiatives

  Information on applying for New Active Substance Work Sharing Initiative (NASWSI) and Biosimilar Work Sharing Initiative (BSWSI) assessments and list of approved products.

  • Updated: 9 July 2026
• Check drug analysis profiles (iDAPs)

  Check what side effects people have reported when they have taken a medicine.
• Evaluation of medicines to prevent COVID-19

  How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.

  • Updated: 31 March 2023
• Authorised veterinary medicines containing controlled drugs

  List of currently authorised veterinary medicines containing controlled drugs (CDs) and their requirements for special storage and witnessed destruction.

  • Updated: 7 July 2026
• Report a product defect: veterinary medicine

  How a marketing authorisation holder should report a defect with a veterinary medicine.

  • Updated: 2 April 2026
• MHRA approves Linerixibat (Lynavoy) for the treatment of itch due to biliary tract disease

  As with all medicines, we will continue to closely monitor the safety and effectiveness of linerixibat as it is used more widely.

  • Updated: 1 May 2026